Bbva Compass Bancshares Inc. reduced its position in shares of Balchem Corporation (NASDAQ:BCPC) by 7.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,692 shares of the basic materials company’s stock after selling 224 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Balchem Corporation were worth $209,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in BCPC. Great West Life Assurance Co. Can increased its stake in shares of Balchem Corporation by 3.8% in the second quarter. Great West Life Assurance Co. Can now owns 45,991 shares of the basic materials company’s stock worth $3,570,000 after buying an additional 1,678 shares in the last quarter. American Capital Management Inc. purchased a new stake in shares of Balchem Corporation during the second quarter worth $218,000. Municipal Employees Retirement System of Michigan increased its stake in shares of Balchem Corporation by 4.0% in the second quarter. Municipal Employees Retirement System of Michigan now owns 7,500 shares of the basic materials company’s stock worth $583,000 after buying an additional 290 shares in the last quarter. Congress Asset Management Co. MA increased its stake in shares of Balchem Corporation by 9.6% in the second quarter. Congress Asset Management Co. MA now owns 19,858 shares of the basic materials company’s stock worth $1,543,000 after buying an additional 1,738 shares in the last quarter. Finally, Tributary Capital Management LLC increased its stake in shares of Balchem Corporation by 11.9% in the second quarter. Tributary Capital Management LLC now owns 187,925 shares of the basic materials company’s stock worth $14,604,000 after buying an additional 19,973 shares in the last quarter. Institutional investors and hedge funds own 85.34% of the company’s stock.

Shares of Balchem Corporation (NASDAQ:BCPC) opened at 75.03 on Friday. The firm has a market capitalization of $2.40 billion, a P/E ratio of 38.88 and a beta of 1.10. The company has a 50 day moving average of $77.45 and a 200-day moving average of $80.89. Balchem Corporation has a 12 month low of $65.37 and a 12 month high of $89.50.

Balchem Corporation (NASDAQ:BCPC) last announced its earnings results on Friday, August 4th. The basic materials company reported $0.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a return on equity of 14.99% and a net margin of 10.99%. The business had revenue of $147.08 million for the quarter. Analysts predict that Balchem Corporation will post $2.48 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/11/bbva-compass-bancshares-inc-has-209000-position-in-balchem-corporation-nasdaqbcpc.html.

Separately, BidaskClub downgraded shares of Balchem Corporation from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st.

In related news, Director Edward Mcmillan sold 2,557 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $81.09, for a total value of $207,347.13. Following the sale, the director now directly owns 25,739 shares in the company, valued at $2,087,175.51. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.59% of the company’s stock.

Balchem Corporation Company Profile

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Corporation (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem Corporation (NASDAQ:BCPC)

Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.